- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00043927
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
20 agosto 2013 aggiornato da: GlaxoSmithKline
An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer.
This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy.
One treatment will use an investigational drug in combination with an FDA approved chemotherapy.
The other treatment will use a combination of two FDA approved chemotherapy drugs.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione
760
Fase
- Fase 3
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Vienna, Austria, A-1090
- GSK Clinical Trials Call Center
-
Vienna, Austria, A-1130
- GSK Clinical Trials Call Center
-
Vienna, Austria, A-1140
- GSK Clinical Trials Call Center
-
-
-
-
-
Charleroi, Belgio, 6000
- GSK Clinical Trials Call Center
-
Edegem, Belgio, 2650
- GSK Clinical Trials Call Center
-
Haine-Saint- Paul, Belgio, 7100
- GSK Clinical Trials Call Center
-
Leuven, Belgio, 3000
- GSK Clinical Trials Call Center
-
Liege, Belgio, 4000
- GSK Clinical Trials Call Center
-
Luxembourg, Belgio, 1210
- GSK Clinical Trials Call Center
-
-
-
-
-
Belo Horizonte, Brasile, 30140-083
- GSK Clinical Trials Call Center
-
Caxias do Sul, Brasile, 95010-060
- GSK Clinical Trials Call Center
-
Fortaleza, Brasile, 60430-230
- GSK Clinical Trials Call Center
-
Porto Alegre, Brasile, 90020-090
- GSK Clinical Trials Call Center
-
Porto Alegre, Brasile, 90035-003
- GSK Clinical Trials Call Center
-
Rio de Janeiro, Brasile, 20230-130
- GSK Clinical Trials Call Center
-
Salvador, Brasile, 41920-000
- GSK Clinical Trials Call Center
-
Sao Paulo, Brasile, 04023-062
- GSK Clinical Trials Call Center
-
Sao Paulo, Brasile, 05403-900
- GSK Clinical Trials Call Center
-
-
-
-
-
Bourgas, Bulgaria, 8000
- GSK Clinical Trials Call Center
-
Plovdiv, Bulgaria, 4000
- GSK Clinical Trials Call Center
-
Sofia, Bulgaria, 1000/1527
- GSK Clinical Trials Call Center
-
Sofia, Bulgaria, 1156
- GSK Clinical Trials Call Center
-
Varna, Bulgaria, 9010
- GSK Clinical Trials Call Center
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N2
- GSK Clinical Trials Call Center
-
Edmonton, Alberta, Canada, T6G 1E2
- GSK Clinical Trials Call Center
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 0V9
- GSK Clinical Trials Call Center
-
-
Nova Scotia
-
Sydney, Nova Scotia, Canada, B1P 1P3
- GSK Clinical Trials Call Center
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y 2P9
- GSK Clinical Trials Call Center
-
Oshawa, Ontario, Canada, L1G 2B9
- GSK Clinical Trials Call Center
-
Ottawa, Ontario, Canada, K1H 1C4
- GSK Clinical Trials Call Center
-
Peterborough, Ontario, Canada, K9H 7B6
- GSK Clinical Trials Call Center
-
Sault Sainte Marie, Ontario, Canada, P6B 1Y5
- GSK Clinical Trials Call Center
-
Thunder Bay, Ontario, Canada, P7B 6V4
- GSK Clinical Trials Call Center
-
Toronto, Ontario, Canada, M5G 2M9
- GSK Clinical Trials Call Center
-
Weston, Ontario, Canada, M9N 1N8
- GSK Clinical Trials Call Center
-
-
Quebec
-
Greenfield Park, Quebec, Canada, J4V 2H1
- GSK Clinical Trials Call Center
-
Montreal, Quebec, Canada, H1T 2M4
- GSK Clinical Trials Call Center
-
Montreal, Quebec, Canada, H2L 4M1
- GSK Clinical Trials Call Center
-
Montreal, Quebec, Canada, H3T 1E2
- GSK Clinical Trials Call Center
-
Sainte-Foy, Quebec, Canada, G1V 4G5
- GSK Clinical Trials Call Center
-
-
-
-
-
Santiago, Chile
- GSK Clinical Trials Call Center
-
-
-
-
-
Beijing, Cina, 100036
- GSK Clinical Trials Call Center
-
Shanghai, Cina, 200433
- GSK Clinical Trials Call Center
-
Wangfujing, Cina, 100730
- GSK Clinical Trials Call Center
-
Xian, Cina, 710061
- GSK Clinical Trials Call Center
-
-
-
-
-
Seoul, Corea, Repubblica di, 110-744
- GSK Clinical Trials Call Center
-
Seoul, Corea, Repubblica di, 120-752
- GSK Clinical Trials Call Center
-
-
-
-
-
San Jose, Costa Rica
- GSK Clinical Trials Call Center
-
-
-
-
-
Tallinn, Estonia, 11619
- GSK Clinical Trials Call Center
-
-
-
-
-
Moscow, Federazione Russa, 107 055
- GSK Clinical Trials Call Center
-
Moscow, Federazione Russa, 115 478
- GSK Clinical Trials Call Center
-
Moscow Region, Federazione Russa, 143 423
- GSK Clinical Trials Call Center
-
-
-
-
-
Helsinki, Finlandia, 29
- GSK Clinical Trials Call Center
-
Kangasala, Finlandia, 36280
- GSK Clinical Trials Call Center
-
Oulu, Finlandia, 90029
- GSK Clinical Trials Call Center
-
-
-
-
-
Caen, Francia, 14076
- GSK Clinical Trials Call Center
-
Calais Cedex, Francia, 62107
- GSK Clinical Trials Call Center
-
Strasbourg, Francia, 67091
- GSK Clinical Trials Call Center
-
Vesoul, Francia, 70014
- GSK Clinical Trials Call Center
-
-
-
-
-
Grosshansdorf, Germania, 22927
- GSK Clinical Trials Call Center
-
-
Baden-Wurttemberg
-
Heidelberg, Baden-Wurttemberg, Germania, 69126
- GSK Clinical Trials Call Center
-
-
Bayern
-
Ebensfeld, Bayern, Germania, 96250
- GSK Clinical Trials Call Center
-
Gauting, Bayern, Germania, 82131
- GSK Clinical Trials Call Center
-
-
-
-
-
Kingston, Giamaica
- GSK Clinical Trials Call Center
-
-
-
-
-
Tegucigalpa, Honduras
- GSK Clinical Trials Call Center
-
-
-
-
-
Lazio, Italia, 149
- GSK Clinical Trials Call Center
-
Roma, Italia, 149
- GSK Clinical Trials Call Center
-
Roma, Italia, 184
- GSK Clinical Trials Call Center
-
-
Liguria
-
Genova, Liguria, Italia, 16132
- GSK Clinical Trials Call Center
-
-
-
-
-
Kaunas, Lituania, LT-45434
- GSK Clinical Trials Call Center
-
Vilnius, Lituania, LT-08660
- GSK Clinical Trials Call Center
-
-
-
-
-
Chihuahua, Messico, 31000
- GSK Clinical Trials Call Center
-
Guadalajara, Messico, 44280
- GSK Clinical Trials Call Center
-
Guadalajara, Messico, 45170
- GSK Clinical Trials Call Center
-
Mexico City, Messico, 14000
- GSK Clinical Trials Call Center
-
-
-
-
-
Oslo, Norvegia, 407
- GSK Clinical Trials Call Center
-
-
-
-
-
Hamilton, Nuova Zelanda, 2001
- GSK Clinical Trials Call Center
-
Wellington South, Nuova Zelanda, 6002
- GSK Clinical Trials Call Center
-
-
-
-
-
Apeldoorn, Olanda, 7334 DZ
- GSK Clinical Trials Call Center
-
Arnheim, Olanda, 6815 AD
- GSK Clinical Trials Call Center
-
Ede, Olanda, 6716 RP
- GSK Clinical Trials Call Center
-
Harderwijk, Olanda, 3844 DG
- GSK Clinical Trials Call Center
-
Nieuwegein, Olanda, 3435 CM
- GSK Clinical Trials Call Center
-
-
-
-
-
Panama, Panama
- GSK Clinical Trials Call Center
-
-
-
-
-
Gdansk, Polonia, 80-211
- GSK Clinical Trials Call Center
-
Kielce, Polonia, 25-640
- GSK Clinical Trials Call Center
-
-
-
-
-
Ponce, Porto Rico, 716
- GSK Clinical Trials Call Center
-
-
-
-
-
Glasgow, Regno Unito, G4 0SF
- GSK Clinical Trials Call Center
-
Leeds, Regno Unito, LS16 6QB
- GSK Clinical Trials Call Center
-
Leicester, Regno Unito, LE1 5WW
- GSK Clinical Trials Call Center
-
Poole, Regno Unito, BH15 2JB
- GSK Clinical Trials Call Center
-
-
Aberdeenshire
-
Aberdeen, Aberdeenshire, Regno Unito, AB25 2ZD
- GSK Clinical Trials Call Center
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, Regno Unito, NG5 1PB
- GSK Clinical Trials Call Center
-
-
-
-
-
Hradec Kralove, Repubblica Ceca, 500 05
- GSK Clinical Trials Call Center
-
Olomouc, Repubblica Ceca, 775 25
- GSK Clinical Trials Call Center
-
Plzen, Repubblica Ceca, 305 99
- GSK Clinical Trials Call Center
-
Praha, Repubblica Ceca, 121 00
- GSK Clinical Trials Call Center
-
Praha, Repubblica Ceca, 150 05
- GSK Clinical Trials Call Center
-
-
-
-
-
Singapore, Singapore, 119074
- GSK Clinical Trials Call Center
-
-
-
-
-
Banska Bystrica, Slovacchia, 975 17
- GSK Clinical Trials Call Center
-
Bratislava, Slovacchia, 825 56
- GSK Clinical Trials Call Center
-
Kosice, Slovacchia, 041 09
- GSK Clinical Trials Call Center
-
Nitra, Slovacchia, 949 88
- GSK Clinical Trials Call Center
-
-
-
-
-
Lerida, Spagna, 25198
- GSK Clinical Trials Call Center
-
Valencia, Spagna, 46009
- GSK Clinical Trials Call Center
-
-
-
-
Alabama
-
Hoover, Alabama, Stati Uniti, 35216
- GSK Clinical Trials Call Center
-
-
California
-
Chula Vista, California, Stati Uniti, 91911
- GSK Clinical Trials Call Center
-
Fountain Valley, California, Stati Uniti, 92708
- GSK Clinical Trials Call Center
-
Greenbrae, California, Stati Uniti, 94904
- GSK Clinical Trials Call Center
-
Poway, California, Stati Uniti, 92064
- GSK Clinical Trials Call Center
-
Rancho Mirage, California, Stati Uniti, 92270
- GSK Clinical Trials Call Center
-
Sacramento, California, Stati Uniti, 95816-5616
- GSK Clinical Trials Call Center
-
San Diego, California, Stati Uniti, 92102-8421
- GSK Clinical Trials Call Center
-
San Diego, California, Stati Uniti, 92121
- GSK Clinical Trials Call Center
-
Soquel, California, Stati Uniti, 95073
- GSK Clinical Trials Call Center
-
Vista, California, Stati Uniti, 92083
- GSK Clinical Trials Call Center
-
-
Colorado
-
Colorado Springs, Colorado, Stati Uniti, 80909
- GSK Clinical Trials Call Center
-
-
Connecticut
-
Norwich, Connecticut, Stati Uniti, 06360
- GSK Clinical Trials Call Center
-
-
District of Columbia
-
Washington, District of Columbia, Stati Uniti, 20307-5001
- GSK Clinical Trials Call Center
-
-
Florida
-
Gainesville, Florida, Stati Uniti, 32610
- GSK Clinical Trials Call Center
-
Miami Shores, Florida, Stati Uniti, 33138
- GSK Clinical Trials Call Center
-
Ocala, Florida, Stati Uniti, 34471
- GSK Clinical Trials Call Center
-
Pensacola, Florida, Stati Uniti, 32501
- GSK Clinical Trials Call Center
-
Tarpon Springs, Florida, Stati Uniti, 34689
- GSK Clinical Trials Call Center
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30030
- GSK Clinical Trials Call Center
-
Atlanta, Georgia, Stati Uniti, 30308
- GSK Clinical Trials Call Center
-
Atlanta, Georgia, Stati Uniti, 30328
- GSK Clinical Trials Call Center
-
Atlanta, Georgia, Stati Uniti, 30335
- GSK Clinical Trials Call Center
-
Augusta, Georgia, Stati Uniti, 30912
- GSK Clinical Trials Call Center
-
Cummings, Georgia, Stati Uniti, 30040
- GSK Clinical Trials Call Center
-
Decatur, Georgia, Stati Uniti, 30033
- GSK Clinical Trials Call Center
-
-
Illinois
-
Aurora, Illinois, Stati Uniti, 60506
- GSK Clinical Trials Call Center
-
Chicago, Illinois, Stati Uniti, 60612
- GSK Clinical Trials Call Center
-
Chicago, Illinois, Stati Uniti, 60637-1470
- GSK Clinical Trials Call Center
-
Elk Grove Village, Illinois, Stati Uniti, 60007
- GSK Clinical Trials Call Center
-
Park Ridge, Illinois, Stati Uniti, 60068
- GSK Clinical Trials Call Center
-
-
Indiana
-
Evansville, Indiana, Stati Uniti, 47713
- GSK Clinical Trials Call Center
-
South Bend, Indiana, Stati Uniti, 46601
- GSK Clinical Trials Call Center
-
-
Louisiana
-
New Orleans, Louisiana, Stati Uniti, 70112
- GSK Clinical Trials Call Center
-
Shreveport, Louisiana, Stati Uniti, 71103
- GSK Clinical Trials Call Center
-
-
Maryland
-
Frederick, Maryland, Stati Uniti, 21701
- GSK Clinical Trials Call Center
-
-
Massachusetts
-
Pittsfield, Massachusetts, Stati Uniti, 01201
- GSK Clinical Trials Call Center
-
-
Minnesota
-
Minneapolis, Minnesota, Stati Uniti, 55404
- GSK Clinical Trials Call Center
-
-
Missouri
-
St. Louis, Missouri, Stati Uniti, 63141
- GSK Clinical Trials Call Center
-
-
Nevada
-
Reno, Nevada, Stati Uniti, 89502
- GSK Clinical Trials Call Center
-
-
New Jersey
-
Voorhees, New Jersey, Stati Uniti, 08043
- GSK Clinical Trials Call Center
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87109
- GSK Clinical Trials Call Center
-
-
New York
-
Albany, New York, Stati Uniti, 12208
- GSK Clinical Trials Call Center
-
New York, New York, Stati Uniti, 10021
- GSK Clinical Trials Call Center
-
New York, New York, Stati Uniti, 10032
- GSK Clinical Trials Call Center
-
Rochester, New York, Stati Uniti, 14623
- GSK Clinical Trials Call Center
-
Valhalla, New York, Stati Uniti, 10595
- GSK Clinical Trials Call Center
-
-
North Dakota
-
Bismarck, North Dakota, Stati Uniti, 58501
- GSK Clinical Trials Call Center
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44106-5065
- GSK Clinical Trials Call Center
-
Columbus, Ohio, Stati Uniti, 43222
- GSK Clinical Trials Call Center
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97232-2099
- GSK Clinical Trials Call Center
-
-
Pennsylvania
-
Lemoyne, Pennsylvania, Stati Uniti, 17043
- GSK Clinical Trials Call Center
-
Limerick, Pennsylvania, Stati Uniti, 19468
- GSK Clinical Trials Call Center
-
Philadelphia, Pennsylvania, Stati Uniti, 19140
- GSK Clinical Trials Call Center
-
-
South Carolina
-
Columbia, South Carolina, Stati Uniti, 29203
- GSK Clinical Trials Call Center
-
Spartanburg, South Carolina, Stati Uniti, 29303
- GSK Clinical Trials Call Center
-
-
Tennessee
-
Memphis, Tennessee, Stati Uniti, 38119
- GSK Clinical Trials Call Center
-
-
Texas
-
Fort Worth, Texas, Stati Uniti, 76104
- GSK Clinical Trials Call Center
-
Houston, Texas, Stati Uniti, 77060
- GSK Clinical Trials Call Center
-
-
Virginia
-
Abingdon, Virginia, Stati Uniti, 24211
- GSK Clinical Trials Call Center
-
Norfolk, Virginia, Stati Uniti, 23502
- GSK Clinical Trials Call Center
-
-
Washington
-
Olympia, Washington, Stati Uniti, 98506
- GSK Clinical Trials Call Center
-
Yakima, Washington, Stati Uniti, 98902
- GSK Clinical Trials Call Center
-
-
West Virginia
-
Morgantown, West Virginia, Stati Uniti, 26506
- GSK Clinical Trials Call Center
-
-
Wisconsin
-
Madison, Wisconsin, Stati Uniti, 53792
- GSK Clinical Trials Call Center
-
-
Wyoming
-
Laramie, Wyoming, Stati Uniti, 82070
- GSK Clinical Trials Call Center
-
-
-
-
Gauteng
-
Johannesburg, Gauteng, Sud Africa, 2193
- GSK Clinical Trials Call Center
-
-
-
-
-
Taipei, Taiwan, 100
- GSK Clinical Trials Call Center
-
Taipei, Taiwan, 105
- GSK Clinical Trials Call Center
-
-
-
-
-
Budapest, Ungheria, 1529
- GSK Clinical Trials Call Center
-
Hungary, Ungheria, 8900
- GSK Clinical Trials Call Center
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
18 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- Written informed consent (patient's written understanding of and agreement to participate in this study).
- Patients with confirmed extensive small cell lung cancer (SCLC).
- No prior chemotherapy within 5 years of the diagnosis of SCLC.
- Presence of either measurable or non-measurable SCLC by X-ray or physical examination.
- At least 3 weeks since last major surgery (a lesser period is acceptable if decided to be in the best interest of the patient).
- At least 24 hours since prior radiotherapy. Patients who have received radiotherapy must have recovered from any reversible side effects, such as nausea and vomiting.
- Laboratory criteria: Patients must have adequate bone marrow reserve and adequate kidney and liver function.
Exclusion Criteria:
- Symptoms of spreading of the disease to the brain that requires treatment with drugs called steroids.
- Any active infection.
- Severe medical problems other than the diagnosis of SCLC, that would limit the ability of the patient to follow study guidelines or that would expose the patient to extreme risk.
- Ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of SCLC.
- Use of an investigational drug within 30 days before the first dose of study medication.
- Women who are pregnant or lactating.
- Patients of child-bearing potential who refuse to practice an adequate form of birth control.
- Patients with clinical evidence of any stomach or intestinal (GI) condition.
- Patients requiring treatment with the drug cyclosporin A.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
---|
Sopravvivenza globale
|
Misure di risultato secondarie
Misura del risultato |
---|
response rates, response duration, time to progression, tolerability and patient-perceived disease status and well being for patients
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Direttore dello studio: GSK Clinical Trial, MD, GlaxoSmithKline
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 aprile 2001
Completamento primario (Effettivo)
1 gennaio 2004
Date di iscrizione allo studio
Primo inviato
14 agosto 2002
Primo inviato che soddisfa i criteri di controllo qualità
15 agosto 2002
Primo Inserito (Stima)
16 agosto 2002
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
21 agosto 2013
Ultimo aggiornamento inviato che soddisfa i criteri QC
20 agosto 2013
Ultimo verificato
1 agosto 2013
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie delle vie respiratorie
- Neoplasie
- Malattie polmonari
- Neoplasie per sede
- Neoplasie delle vie respiratorie
- Neoplasie toraciche
- Carcinoma, broncogeno
- Neoplasie bronchiali
- Neoplasie polmonari
- Carcinoma polmonare a piccole cellule
- Meccanismi molecolari dell'azione farmacologica
- Inibitori enzimatici
- Agenti antineoplastici
- Agenti antineoplastici, fitogenici
- Inibitori della topoisomerasi II
- Inibitori della topoisomerasi
- Inibitori della topoisomerasi I
- Etoposide
- Cisplatino
- Topotecan
Altri numeri di identificazione dello studio
- 104864-A/389
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Cancro polmonare a piccole cellule
-
National Cancer Institute (NCI)ReclutamentoKita-kyushu Lung Cancer Antigen 1, umanoStati Uniti
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group BCompletatoCarcinoma a cellule renali a cellule chiare | Cancro a cellule renali in stadio III AJCC v7 | Cancro a cellule renali in stadio II AJCC v7 | Stadio I Renal Cell Cancer AJCC v6 e v7Stati Uniti, Canada, Porto Rico
-
National Cancer Institute (NCI)TerminatoCarcinoma a cellule renali a cellule chiare | Carcinoma a cellule renali metastatico | Cancro a cellule renali in stadio III AJCC v7 | Cancro a cellule renali in stadio IV AJCC v7 | Cancro a cellule renali in stadio II AJCC v7 | Stadio I Renal Cell Cancer AJCC v6 e v7Stati Uniti
Prove cliniche su topotecan/cisplatin
-
Korea Cancer Center HospitalCompletatoNEOPLASMI CERVICALICorea, Repubblica di
-
Targeted Therapy Technologies, LLCAttivo, non reclutante
-
The Hospital for Sick ChildrenReclutamentoRetinoblastomaCanada
-
Gustave Roussy, Cancer Campus, Grand ParisErasmus Medical Center; Catholic University of the Sacred Heart; St. Anna KinderkrebsforschungCompletatoNeuroblastoma | Tumori solidi | Tumori cerebraliFrancia
-
Hospital JP GarrahanHospital San Juan de Dios, SantiagoAttivo, non reclutanteRetinoblastoma unilateraleArgentina
-
GlaxoSmithKlineCompletato
-
GlaxoSmithKlineCompletatoTumore endometriale | Neoplasie, endometrioStati Uniti, Canada, Ungheria
-
Gachon University Gil Medical CenterSconosciutoCancro ai polmoni | Refrattaria alla chemioterapiaCorea, Repubblica di
-
GlaxoSmithKlineCompletatoCancro polmonare, piccola cellulaStati Uniti, Olanda
-
GlaxoSmithKlineCompletatoCancro polmonare, piccola cellulaBulgaria, Ungheria, Federazione Russa, Olanda, Ucraina, Regno Unito